
A trial of the drug sildenafil, commonly sold under the brand name Viagra, has been halted immediately after the death …

Takeda announced that it had completed the enrolment for the largest clinical trial in its history, having enrolled 20,100 children …

AstraZeneca’s clinical trial for head and neck cancer had previously been put on partial hold by the FDA due to …
Acorda Therapeutics announced that they were unable to continue development of the drug, dalfampridine, due to lack of efficacy in …

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …

The European Medicines Agency (EMA) has announced that it will conduct a review in an attempt to revise its guidelines …

Authorities in France have criticised the pharmaceutical company and the clinical research organisation at the centre of the Rennes clinical …
Bayer has terminated a Phase II trial evaluating riociguat in patients with pulmonary hypertension due to fears raised by an …

Victims of the recent Paris terror attacks have been offered the opportunity to take part in a clinical trial, organised …

AstraZeneca and Eli Lilly have announced the continuation of their clinical trial for people with early Alzheimer’s disease into Phase …

A cross collaboration between industry and not-for-profit organisations will see Ludwig Cancer Research and the Cancer Research Institute partner with …

Novartis has announced results from the PARADIGM-HF clinical trial that show that Entresto (sacubitril/valsartan) consistently demonstrated benefit among heart failure …

Keryx Biopharmaceuticals (NASDAQ: KERX) has announced positive top-line results for its Phase III study of ferric citrate for the treatment …

Astellas Pharma (TSE: 4503) and Medivation (NASDAQ:MDVN) have announced the initiation of the ARCHES Phase III clinical trial to evaluate …

Amgen (NASDAQ:AMGN) and UCB (EBR:UCB) have announced positive top line results for romosozumab in men with osteoporosis in the Phase …